These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2008-001807-53||Essai de phase II d’évaluation de l’efficacité et de la tolérance du bevacizumab (AVASTIN®) dans les cancers du sein inflammatoire HER2-.||not-yet-due|